Drug Recalls Deep Dive
Drug recalls are actions taken to remove a defective or potentially harmful product from the market. Pharmacy technicians play an important role in identifying, removing, and managing recalled products. This guide covers the recall process, classification system, and pharmacy responsibilities.
What Triggers a Drug Recall?
Recalls may be initiated when a product is found to be:
- Contaminated (microbial, chemical, or foreign matter contamination)
- Mislabeled (incorrect strength, wrong drug name, missing information)
- Adulterated (does not meet quality standards)
- Improperly manufactured (deviations from Good Manufacturing Practices)
- Lacking in potency or stability
- Packaged with incorrect dosing instructions
Who Initiates Recalls?
- Manufacturer (voluntary): Most recalls are initiated voluntarily by the manufacturer or distributor after discovering a problem.
- FDA (mandatory): The FDA can mandate a recall if the manufacturer does not act voluntarily and there is a reasonable probability that the product is harmful.
- The FDA classifies the recall and monitors the recall process but, in most cases, the manufacturer conducts the actual recall.
Recall Classifications
| Class | Definition | Examples |
|---|---|---|
| Class I | Reasonable probability that use of the product will cause serious adverse health consequences or death. | Contamination with a pathogenic organism, labeling error that results in a dangerous dose, products containing undeclared allergens |
| Class II | Use of the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse consequences is remote. | Drugs not meeting dissolution specifications, products with incorrect potency that is not immediately dangerous |
| Class III | Use of the product is not likely to cause adverse health consequences. | Minor labeling errors (wrong batch number on label), packaging defects that do not affect product quality |
FDA Safety Communications
- Safety Alert: An urgent notification about a serious safety concern with a drug product.
- Market Withdrawal: A product has a minor defect that does not rise to the level of a recall. The manufacturer removes it voluntarily from the market.
- Medical Device Safety Alert: Similar to drug recalls but specific to medical devices.
Pharmacy Recall Procedures
When a recall notification is received, the pharmacy should follow these steps:
- Identify affected products: Check the recall notice for specific lot numbers, NDC numbers, expiration dates, and product descriptions.
- Search inventory: Check shelves, storage areas, automated dispensing systems, and any satellite locations for affected products.
- Remove and quarantine: Pull affected products from active inventory and place them in a clearly marked quarantine area. Do not dispose of them unless instructed.
- Notify the pharmacist: The pharmacist-in-charge must be informed of any recall actions.
- Check dispensing records: Determine if any recalled product was dispensed to patients.
- Patient notification: For Class I recalls, notify patients who received the recalled product as directed. The pharmacist should contact patients and their prescribers as needed.
- Return the product: Follow the manufacturer's or wholesaler's instructions for returning recalled products. Maintain documentation of all returns.
- Document everything: Record the recall notice details, actions taken, products removed, patients notified, and products returned.
MedWatch and Adverse Event Reporting
The FDA's MedWatch program allows healthcare professionals and consumers to report:
- Adverse events (unexpected side effects or drug reactions)
- Product quality problems (contamination, degraded products)
- Medication errors
- Product use errors
Reports can be submitted online through the FDA's MedWatch website or via FDA Form 3500 (voluntary reporting by healthcare professionals) or Form 3500A (mandatory reporting by manufacturers).
Drug Supply Chain Security Act (DSCSA)
The DSCSA, also known as the "track and trace" law, establishes requirements for tracking prescription drugs through the supply chain. Key provisions:
- Manufacturers must assign a unique product identifier (serialization) to each drug package.
- Each entity in the supply chain (manufacturer, wholesaler, pharmacy) must exchange transaction information when products change hands.
- Transaction documentation includes: Transaction Information (TI), Transaction History (TH), and Transaction Statement (TS).
- Pharmacies must verify product identifiers before dispensing and investigate suspect or illegitimate products.
- The law helps prevent counterfeit, stolen, or contaminated drugs from reaching patients.
Lot Numbers and Expiration Dates
Understanding lot numbers and expiration dates is critical for recall management:
- Lot number (batch number): A unique identifier assigned by the manufacturer to a specific batch of product. All units in a lot were manufactured under the same conditions. Recalls target specific lot numbers.
- Expiration date: The date after which the manufacturer cannot guarantee the product's potency and safety. A drug with an expiration date of "08/2026" expires on the last day of August 2026.
- When checking for a recalled lot, match both the NDC and lot number to confirm whether the product is affected.
Exam Tips
- Know the three recall classes: Class I is the most serious (risk of death or serious harm); Class III is the least serious.
- Most recalls are voluntary (initiated by the manufacturer), not mandatory FDA actions.
- The pharmacy must remove, quarantine, and document all recalled products.
- MedWatch is the FDA's system for reporting adverse events and product problems.
- The DSCSA requires serialization and tracking of drugs through the supply chain.
- Lot numbers are the key identifier in recall management - always match the lot number, not just the drug name.